Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
Kashyap A, Wingard J, Cagnoni P, Roy J, Tarantolo S, Hu W, Blume K, Niland J, Palmer JM, Vaughan W, Fernandez H, Champlin R, Forman S, Andersson BS. Kashyap A, et al. Biol Blood Marrow Transplant. 2002;8(9):493-500. doi: 10.1053/bbmt.2002.v8.pm12374454. Biol Blood Marrow Transplant. 2002. PMID: 12374454 Free article. Clinical Trial.
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.
Andersson BS, Kashyap A, Gian V, Wingard JR, Fernandez H, Cagnoni PJ, Jones RB, Tarantolo S, Hu WW, Blume KG, Forman SJ, Champlin RE. Andersson BS, et al. Among authors: hu ww. Biol Blood Marrow Transplant. 2002;8(3):145-54. doi: 10.1053/bbmt.2002.v8.pm11939604. Biol Blood Marrow Transplant. 2002. PMID: 11939604 Free article. Clinical Trial.
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Cao TM, Horning S, Negrin RS, Hu WW, Johnston LJ, Taylor TL, Shizuru JA, Hoppe RT, Brown BW, Blume KG, Stockerl-Goldstein KE. Cao TM, et al. Among authors: hu ww. Biol Blood Marrow Transplant. 2001;7(5):294-301. doi: 10.1053/bbmt.2001.v7.pm11400952. Biol Blood Marrow Transplant. 2001. PMID: 11400952 Free article.
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG. Long GD, et al. Among authors: hu ww. Biol Blood Marrow Transplant. 1997 Dec;3(6):324-30. Biol Blood Marrow Transplant. 1997. PMID: 9502300 Clinical Trial.
268 results